Journal Information

Statistics

Follow this link to access the full text of the article

ORIGINALS
Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
Adherencia al tratamiento con adalimumab, golimumab y ustekinumab en pacientes con enfermedad inflamatoria intestinal
María Calvo-Arbeloa1,
, Ana María Insausti-Serrano2, Amaya Arrondo-Velasco1, María Teresa Sarobe-Carricas1
1 Pharmacy Department, Complejo Hospitalario de Navarra, Pamplona. Spain
2 School of Health Sciences, Universidad Pública de Navarra, Tudela. Spain
Read
1517
Times
was read the article
466
Total PDF
1051
Total HTML
Share statistics
Article information
ISSN: 11306343
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 7 48 25 73
2025 6 63 29 92
2025 5 101 36 137
2025 4 69 23 92
2025 3 79 23 102
2025 2 68 31 99
2025 1 66 28 94
2024 12 52 18 70
2024 11 38 27 65
2024 10 56 24 80
2024 9 47 16 63
2024 8 40 29 69
2024 7 36 17 53
2024 6 35 31 66
2024 5 50 28 78
2024 4 40 19 59
2024 3 34 14 48
2024 2 32 13 45
2024 1 56 14 70
2023 12 32 7 39
2023 11 9 14 23
Show all

Follow this link to access the full text of the article

Idiomas
Farmacia Hospitalaria
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.